CHINESE JOURNAL OF DRUG EVALUATION >

2026 , Vol. 43 >Issue 2: 86 - 86-89

DOI: https://doi.org/10.2095-3593.2026.040002

Common Problems and Analysis of Tibetan Medicine Preparation Filing in Medical Institutions in Qinghai Province

Expand
  • Drug Evaluation and Verification Center of Qinghai Province， Qinghai Xining 810000， China

Received date: 2025-11-11

  Revised date: 2026-01-17

  Accepted date: 2026-05-19

  Online published: 2026-05-19

Fold

Abstract

Objective： To summarize and analyze the problems found in the preparation record data of ethnic medical institutions in our province， and to explore the possible solutions and ideas under the new situation of encouraging the development of ethnic medicine and ensuring the safety of public drug use， so as to provide reference for the formulation and introduction of guiding policies. Methods： The filing situation of Chinese and Tibetan medicine preparations declared in our province from 2018 to 2022 was investigated， and the filing data of Chinese and Tibetan medicine preparations prepared by traditional technology in medical institutions were collected and analyzed. Results The declaration of preparations for medical institutions needs to be improved in terms of preparation name， functional indications， instructions， process and quality standard research. Conclusion： Medical institutions should strengthen the examination of the scientificity and necessity of the research and development of preparations， and carry out research based on the actual needs of clinical and patients； the regulatory authorities need to speed up the formulation of preparations with multi-unit records and large clinical dosage， and the quality standards of medicinal materials without national standards in the prescriptions， so as to promote the standardized development of preparations in ethnic medical institutions and prosper the cause of ethnic medicine.

Key words： ; font-size:medium; ">Medical institution preparations； Recording； Tibetan medicine preparations； Traditional crafts

Cite this article

SHI Chunlan, NIAN Yongqi, WANG Yongming, LIU Xueliang, CHENG Xiaoping, WANG Yongjing, QI Yankai, HAN Dabin . Common Problems and Analysis of Tibetan Medicine Preparation Filing in Medical Institutions in Qinghai Province[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026 , 43(2) : 86 -86-89 . DOI: 10.2095-3593.2026.040002

References

 [1] 仁真旺甲，何青秀，苏锦松，等. 多基原藏药“唐冲”名称、品种、药性和植物亲缘关系相关性考证研究[J]. 世界科学技术-中医药现代化，2021， 23(10)：3681-3687.
     [2] 杨文娟，聂佳，俞佳，等. 南派藏医药的主要学术特色探析[J]. 时珍国医国药， 2016， 27(7)：1683-1684.
     [3] 曹梦蝶，吴锐，王张，等. 我国批准上市中成药的品种、主治和用药特点[J]. 中成药，2019，41(8)：1999-2006.
     [4] 刘兴昌，倪龙，白晓菊，等. 国家药品标准中成药功能主治规范工作回顾与展望[J]. 中国药品标准，2005，6(4)：30-32.
     [5] 蒋霞，何成章，黄银妹，等. 中药肾毒性评价模型与技术的研究进展[J]. 广西医科大学学报，2017，34(7)：1094-1096.
     [6] 赵燕，王旭，王玉团，等. 中成药国家标准剂量单位计量形式的探索研究(三) [J]. 中国药品标准，2017，18(2)：91-94.
     [7] 孟菲，李学林. 中成药说明书中规格项存在的问题与探讨[J]. 当代医学，2015，21(12)：14-15.
     [8] 陈延芳. 论中成药标准规格的研究和制定[J]. 中成药，1988，(7)：41-42.
     [9] 青监文. 青海省药监局推动中藏药高质量发展[J]. 中医药管理杂志，2020，28(1)：127.
     [10] 骆桂法，杨凤梅，刘海青，等. 青海省藏药质量标准调研报告[J]. 中国药事，2015，29(12)：1272-1277.
     [11] 新华社. 青海省首次通过藏药炮制标准保障藏药生产质量[J]. 中成药，2009，31(3)：426.
     [12] 骆桂法. 青海省藏药炮制规范研究[C]. 中国药学会中药和天然药物专业委员会，浙江省药学会. 2013全国中药与天然药物高峰论坛暨第十三届全国中药和天然药物学术研讨会论文集. 青海省食品药品检验所，2013：70.
Options
Outlines

/

〈 〉

[an error occurred while processing this directive]